Conventional medicine has long focused on treating disease after it appears. Ana challenges this paradigm by advocating for a proactive approach, one that equips society with tools to screen early, anticipate individual risks, and identify personal health vulnerabilities before they evolve into pathology. This shift represents a critical step toward extending healthspan, reducing healthcare costs, and making preventive care a cornerstone of modern medicine.

Through InoHealth, Ana is on a mission to bring advanced wellness and diagnostic tools to the public, enabling meaningful insights that guide effective prevention while reducing the risk of overdiagnosis. Powered by AI-based algorithms and delivered through a user-friendly digital platform, these technologies are designed to serve as the foundation for next-generation diagnostics and future early screening applications.

Today, in her talk “Beyond Normal: Engineering Health Resilience with Data-Driven Biology,” Ana will explore how data-driven biological insights can transform the way we understand risk, strengthen resilience, and reshape the future of preventive healthcare. 

Ana Stankovic is the Chief Scientific Officer and Co-Founder of InoHealth, based in Geneva, Switzerland. With over a decade of interdisciplinary research experience spanning epigenetics, aging, neuroscience, and human physiology, Ana has built a career at the intersection of science and medical innovation. Educated across Europe and the United States, she combines rigorous scientific training with a forward-looking vision for the future of healthcare.

Join us at the Longevity Med Summit 2026 in welcoming Ana Stankovic.